Showing results (71-80 of 411) with videos related to
Sort By:
Pageof 42
Preventive Oncology & Epidemiology|March 25, 2024
Cancer Research in 2030: A unique strategic planning process at a comprehensive cancer centerErin M Bank, Eric J Small, Alan Ashworth, et al.BMC Genomics|July 12, 2011
An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescenceEmilie Rovillain, Louise Mansfield, Christopher J Lord, et al.Human Molecular Genetics|April 4, 2002
Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutationsMadhuri Warren, Amanda Smith, Natalie Partridge, et al.Oncogene|July 25, 2003
Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1James Spicer, Sydonia Rayter, Neville Young, et al.The Journal of Investigative Dermatology|October 26, 2007
Dynamic expression of Erbb pathway members during early mammary gland morphogenesisOlivia Wansbury, Heena Panchal, Michelle James, et al.Cancer Research|January 19, 2011
Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancersSarah A Martin, Madeleine Hewish, David Sims, et al.Molecular Cell|May 23, 2015
The cancer cell map initiative: defining the hallmark networks of cancerNevan J Krogan, Scott Lippman, David A Agard, et al.Nature|August 15, 2003
CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family membersEirini Trompouki, Eudoxia Hatzivassiliou, Theodore Tsichritzis, et al.DNA Repair|October 4, 2008
A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivityChristopher J Lord, Sarah McDonald, Sally Swift, et al.Plos Genetics|June 30, 2010
Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesisJeffrey C Francis, Afshan McCarthy, Martin K Thomsen, et al.Pageof 42